3

OWNERSHIP DOCUMENT

Company: Finch Therapeutics Group, Inc.
Filed: March 18, 2021
Period of Report: March 18, 2021
Accession Number: 0000950142-21-001022

View Document ↗ View on SEC.gov ↗